Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19

Administering N-acetylcysteine (NAC) could counteract the effect of free radicals, improving the clinical evolution of patients admitted to the Intensive Care Unit (ICU). This study aimed to investigate the clinical and biochemical effects of administering NAC to critically ill patients with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamarra-Morales, Yenifer, Herrera-Quintana, Lourdes, Molina-López, Jorge, Vázquez-Lorente, Héctor, Machado-Casas, Juan Francisco, Castaño-Pérez, José, Pérez-Villares, José Miguel, Planells, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181318/
https://www.ncbi.nlm.nih.gov/pubmed/37405379
http://dx.doi.org/10.3390/nu15092235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181318/
https://www.ncbi.nlm.nih.gov/pubmed/37405379
http://dx.doi.org/10.3390/nu15092235

Ejemplares similares